AAPL328.21+3.25 (+1.00%) ▲|ABBV260.21-1.51 (-0.58%) ▼|ABT108.79-1.68 (-1.52%) ▼|ACN193.12+5.44 (+2.90%) ▲|ADBE285.75+5.96 (+2.13%) ▲|AMAT435.91-2.55 (-0.58%) ▼|AMD456.16-0.90 (-0.20%) ▼|AMGN444.12+1.28 (+0.29%) ▲|AMT177.75+4.83 (+2.79%) ▲|AMZN258.90+3.92 (+1.54%) ▲|AVGO357.16-10.08 (-2.74%) ▼|AXP329.82-0.16 (-0.05%) ▼|BA210.51+1.64 (+0.79%) ▲|BAC63.04+0.44 (+0.70%) ▲|BKNG195.13-4.47 (-2.24%) ▼|BLK1,126.15+19.07 (+1.72%) ▲|BMY68.09+0.43 (+0.64%) ▲|BNY164.33+2.29 (+1.41%) ▲|BRK-B508.13+2.89 (+0.57%) ▲|C138.14+3.80 (+2.83%) ▲|CAT800.14+7.86 (+0.99%) ▲|CL90.09-0.01 (-0.01%) ▼|CMCSA26.65-0.16 (-0.60%) ▼|COF220.50+3.90 (+1.80%) ▲|COP135.72-1.48 (-1.08%) ▼|COST925.41-3.07 (-0.33%) ▼|CRM264.43+7.50 (+2.92%) ▲|CSCO108.61-0.85 (-0.77%) ▼|CVS97.20-0.03 (-0.03%) ▼|CVX211.32-0.46 (-0.22%) ▼|DE694.41-3.96 (-0.57%) ▼|DHR211.03+1.12 (+0.53%) ▲|DIS107.16-0.82 (-0.76%) ▼|DUK121.40+0.84 (+0.70%) ▲|EMR150.21+1.23 (+0.83%) ▲|FDX324.31+7.77 (+2.45%) ▲|GD365.87+1.80 (+0.49%) ▲|GE333.48+3.98 (+1.21%) ▲|GEV941.84+19.90 (+2.16%) ▲|GILD151.22+1.61 (+1.08%) ▲|GM87.22+2.35 (+2.77%) ▲|GOOG339.08+5.30 (+1.59%) ▲|GOOGL342.48+5.36 (+1.59%) ▲|GS1,037.93+33.51 (+3.34%) ▲|HD318.07+1.89 (+0.60%) ▲|HON207.63+1.56 (+0.76%) ▲|IBM234.71+3.01 (+1.30%) ▲|INTC91.67+1.62 (+1.80%) ▲|INTU344.30+1.36 (+0.40%) ▲|ISRG369.83-2.05 (-0.55%) ▼|JNJ278.43+3.22 (+1.17%) ▲|JPM362.06+5.84 (+1.64%) ▲|KO88.81+0.57 (+0.65%) ▲|LIN482.19-3.66 (-0.75%) ▼|LLY1,159.60-0.48 (-0.04%) ▼|LMT532.95+1.40 (+0.26%) ▲|LOW201.90+2.06 (+1.03%) ▲|LRCX292.66+4.34 (+1.51%) ▲|MA585.71-2.43 (-0.41%) ▼|MCD259.63-1.32 (-0.51%) ▼|MDLZ61.45-1.00 (-1.60%) ▼|MDT93.10+0.92 (+1.00%) ▲|META610.68+17.83 (+3.01%) ▲|MMM168.31-0.44 (-0.26%) ▼|MO69.49-0.07 (-0.10%) ▼|MRK152.34+0.70 (+0.46%) ▲|MS217.15+5.33 (+2.52%) ▲|MSFT510.12+13.30 (+2.68%) ▲|MU958.16+2.08 (+0.22%) ▲|NEE84.06+0.96 (+1.16%) ▲|NFLX82.67-0.06 (-0.07%) ▼|NKE38.77+0.53 (+1.39%) ▲|NOW145.59+8.87 (+6.49%) ▲|NVDA228.45+4.04 (+1.80%) ▲|ORCL154.04+8.29 (+5.69%) ▲|PEP140.02-0.50 (-0.36%) ▼|PFE28.81-0.21 (-0.72%) ▼|PG146.92-0.72 (-0.49%) ▼|PLTR182.53+13.07 (+7.71%) ▲|PM186.17-1.77 (-0.94%) ▼|QCOM168.57-0.47 (-0.28%) ▼|RTX200.62-1.51 (-0.74%) ▼|SBUX105.89+0.07 (+0.07%) ▲|SCHW109.82-0.56 (-0.51%) ▼|SO88.78-0.03 (-0.03%) ▼|SPG211.95+0.44 (+0.21%) ▲|T26.18-0.01 (-0.02%) ▼|TMO618.43+9.89 (+1.63%) ▲|TMUS188.02+0.72 (+0.38%) ▲|TSLA376.37+19.36 (+5.42%) ▲|TXN257.46+3.63 (+1.43%) ▲|UBER76.63+0.67 (+0.88%) ▲|UNH398.39-2.56 (-0.64%) ▼|UNP289.85+0.71 (+0.25%) ▲|UPS103.00-0.51 (-0.49%) ▼|USB63.57+0.04 (+0.06%) ▲|V375.47-3.24 (-0.86%) ▼|VZ50.66+0.08 (+0.15%) ▲|WFC89.54+0.35 (+0.39%) ▲|WMT108.64+0.22 (+0.20%) ▲|XOM160.24-2.00 (-1.23%) ▼|AAPL328.21+3.25 (+1.00%) ▲|ABBV260.21-1.51 (-0.58%) ▼|ABT108.79-1.68 (-1.52%) ▼|ACN193.12+5.44 (+2.90%) ▲|ADBE285.75+5.96 (+2.13%) ▲|AMAT435.91-2.55 (-0.58%) ▼|AMD456.16-0.90 (-0.20%) ▼|AMGN444.12+1.28 (+0.29%) ▲|AMT177.75+4.83 (+2.79%) ▲|AMZN258.90+3.92 (+1.54%) ▲|AVGO357.16-10.08 (-2.74%) ▼|AXP329.82-0.16 (-0.05%) ▼|BA210.51+1.64 (+0.79%) ▲|BAC63.04+0.44 (+0.70%) ▲|BKNG195.13-4.47 (-2.24%) ▼|BLK1,126.15+19.07 (+1.72%) ▲|BMY68.09+0.43 (+0.64%) ▲|BNY164.33+2.29 (+1.41%) ▲|BRK-B508.13+2.89 (+0.57%) ▲|C138.14+3.80 (+2.83%) ▲|CAT800.14+7.86 (+0.99%) ▲|CL90.09-0.01 (-0.01%) ▼|CMCSA26.65-0.16 (-0.60%) ▼|COF220.50+3.90 (+1.80%) ▲|COP135.72-1.48 (-1.08%) ▼|COST925.41-3.07 (-0.33%) ▼|CRM264.43+7.50 (+2.92%) ▲|CSCO108.61-0.85 (-0.77%) ▼|CVS97.20-0.03 (-0.03%) ▼|CVX211.32-0.46 (-0.22%) ▼|DE694.41-3.96 (-0.57%) ▼|DHR211.03+1.12 (+0.53%) ▲|DIS107.16-0.82 (-0.76%) ▼|DUK121.40+0.84 (+0.70%) ▲|EMR150.21+1.23 (+0.83%) ▲|FDX324.31+7.77 (+2.45%) ▲|GD365.87+1.80 (+0.49%) ▲|GE333.48+3.98 (+1.21%) ▲|GEV941.84+19.90 (+2.16%) ▲|GILD151.22+1.61 (+1.08%) ▲|GM87.22+2.35 (+2.77%) ▲|GOOG339.08+5.30 (+1.59%) ▲|GOOGL342.48+5.36 (+1.59%) ▲|GS1,037.93+33.51 (+3.34%) ▲|HD318.07+1.89 (+0.60%) ▲|HON207.63+1.56 (+0.76%) ▲|IBM234.71+3.01 (+1.30%) ▲|INTC91.67+1.62 (+1.80%) ▲|INTU344.30+1.36 (+0.40%) ▲|ISRG369.83-2.05 (-0.55%) ▼|JNJ278.43+3.22 (+1.17%) ▲|JPM362.06+5.84 (+1.64%) ▲|KO88.81+0.57 (+0.65%) ▲|LIN482.19-3.66 (-0.75%) ▼|LLY1,159.60-0.48 (-0.04%) ▼|LMT532.95+1.40 (+0.26%) ▲|LOW201.90+2.06 (+1.03%) ▲|LRCX292.66+4.34 (+1.51%) ▲|MA585.71-2.43 (-0.41%) ▼|MCD259.63-1.32 (-0.51%) ▼|MDLZ61.45-1.00 (-1.60%) ▼|MDT93.10+0.92 (+1.00%) ▲|META610.68+17.83 (+3.01%) ▲|MMM168.31-0.44 (-0.26%) ▼|MO69.49-0.07 (-0.10%) ▼|MRK152.34+0.70 (+0.46%) ▲|MS217.15+5.33 (+2.52%) ▲|MSFT510.12+13.30 (+2.68%) ▲|MU958.16+2.08 (+0.22%) ▲|NEE84.06+0.96 (+1.16%) ▲|NFLX82.67-0.06 (-0.07%) ▼|NKE38.77+0.53 (+1.39%) ▲|NOW145.59+8.87 (+6.49%) ▲|NVDA228.45+4.04 (+1.80%) ▲|ORCL154.04+8.29 (+5.69%) ▲|PEP140.02-0.50 (-0.36%) ▼|PFE28.81-0.21 (-0.72%) ▼|PG146.92-0.72 (-0.49%) ▼|PLTR182.53+13.07 (+7.71%) ▲|PM186.17-1.77 (-0.94%) ▼|QCOM168.57-0.47 (-0.28%) ▼|RTX200.62-1.51 (-0.74%) ▼|SBUX105.89+0.07 (+0.07%) ▲|SCHW109.82-0.56 (-0.51%) ▼|SO88.78-0.03 (-0.03%) ▼|SPG211.95+0.44 (+0.21%) ▲|T26.18-0.01 (-0.02%) ▼|TMO618.43+9.89 (+1.63%) ▲|TMUS188.02+0.72 (+0.38%) ▲|TSLA376.37+19.36 (+5.42%) ▲|TXN257.46+3.63 (+1.43%) ▲|UBER76.63+0.67 (+0.88%) ▲|UNH398.39-2.56 (-0.64%) ▼|UNP289.85+0.71 (+0.25%) ▲|UPS103.00-0.51 (-0.49%) ▼|USB63.57+0.04 (+0.06%) ▲|V375.47-3.24 (-0.86%) ▼|VZ50.66+0.08 (+0.15%) ▲|WFC89.54+0.35 (+0.39%) ▲|WMT108.64+0.22 (+0.20%) ▲|XOM160.24-2.00 (-1.23%) ▼|
24.7 C
New York
Friday, September 4, 2026

Tag: study

newssourceFORcompanyinformationcontent1releasesmarket

Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication

Publication of MONITOR-Breast study marks latest milestone for clinical validity of Precise MRD 
Publication of MONITOR-Breast study marks latest milestone for clinical validity of Precise MRD

AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis

SKYRIZI® (risankizumab) expands its indication for children and adolescents six years of age and older with moderate to severe plaque psoriasis1Approval was based on...

AI Data Center Market Projected to Reach USD 810.6 Billion by 2033 as Enterprises Accelerate Investments in AI Infrastructure

Growing Demand for Generative AI, High-Performance Computing, and Cloud-Based AI Workloads Fuels Rapid Expansion of Next-Generation Data CentersSAN FRANCISCO, June 22, 2026 /PRNewswire/ --...

[Latest] Global Onion Powder Market Size/Share Worth USD 2.61 Billion by 2035 at a 6.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends,...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Onion Powder Market size & share revenue was valued at approximately USD 1.34 Billion in 2025 and is expected to reach USD 1.43 Billion in 2026 and is expected to reach around USD 2.61 Billion by 2035, at a CAGR of 6.2% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are McCormick & Company Inc., Olam International Limited, Worlée NaturProdukte GmbH, Garlico Industries Ltd., Dehydrates Inc., Sensient Technologies Corporation, Jain Farm Fresh Foods Ltd., BC Foods, Malabar Gold Spices, Sunbeam Foods Pty Ltd and others. 
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Onion Powder Market size & share revenue was valued at approximately USD 1.34 Billion in 2025 and is expected to reach USD 1.43 Billion in 2026 and is expected to reach around USD 2.61 Billion by 2035, at a CAGR of 6.2% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are McCormick & Company Inc., Olam International Limited, Worlée NaturProdukte GmbH, Garlico Industries Ltd., Dehydrates Inc., Sensient Technologies Corporation, Jain Farm Fresh Foods Ltd., BC Foods, Malabar Gold Spices, Sunbeam Foods Pty Ltd and others.

A Greenland Rare Earth Story Is Accelerating as the West Races to Break China’s Magnet Grip

Issued on behalf of Greenland Mines Ltd.CHARLOTTE, N.C., June 22, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary — As of January 1, 2027, U.S. defense systems...

A Greenland Rare Earth Story Is Accelerating as the West Races to Break China’s Magnet Grip

Issued on behalf of Greenland Mines Ltd.CHARLOTTE, N.C., June 22, 2026 /CNW/ -- USANewsGroup.com News Commentary -- As of January 1, 2027, U.S. defense systems...

Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial

Vancouver, Canada, June 22, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced the successful completion of treatment for all participants in Part A of its ongoing Phase I/II clinical trial evaluating CMND-100 for the treatment of Alcohol Use Disorder (AUD).

Questex’s DPHARM Announces Senior Leadership and Keynotes for the 16th Annual Conference

BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- DPHARM, the leading innovation event for clinical trial operation executives, announces the 16th annual conference agenda including its senior leadership and keynotes. DPHARM which is now part of Questex’s Fierce Life Sciences, takes place September 15-16, 2026, at the Sheraton Boston Hotel.

Period Panties Market to Reach USD 1,100 million by 2036, Driven by Rising Adoption of Reusable Menstrual Products and Growing Consumer Awareness

NEWARK, Del., June 22, 2026 /PRNewswire/ -- According to a comprehensive study by Future Market Insights (FMI), the global Period Panties Market is projected to grow...

Period Panties Market to Reach USD 1,100 million by 2036, Driven by Rising Adoption of Reusable Menstrual Products and Growing Consumer Awareness

NEWARK, Del., June 22, 2026 /PRNewswire/ -- According to a comprehensive study by Future Market Insights (FMI), the global Period Panties Market is projected to grow...

Nura Bio Completes $73.8M Series B Financing and Advances Pipeline of SARM1 Inhibitors

Nura Bio announced the completion of a Series B financing and the advancement of its two clinical-stage SARM1 inhibitor programs

Telia Lietuva acquired frequencies for 5G network for almost EUR 10 million

Telia Lietuva, AB (hereinafter “Telia Lietuva” or “the Company”) acquired two 1,500 MHz frequency blocks for almost EUR 10 million and stood out as the largest investor in the 1,500 MHz frequency band in an auction organized by the Communications Regulatory Authority (CRA). The Company received the largest share of these frequencies sold – 40 MHz, which will be used for further development of the 5G network. Along with this achievement, Telia Lietuva also extended the right to use the 2,100 MHz frequency band in another auction, committing to pay the state another EUR 2 million for this right.

Rock Tech Lithium Expands Made-in-Ontario Lithium Supply Chain with Strategic Acquisition of Victory Project

High-grade spodumene occurrences strategically located near Trans-Canada Highway, CPKC rail, and power infrastructure adds potential feedstock opportunity for Rock Tech's Ontario mine-to-converter platform, linking...

Translational Research Results of Sacituzumab Tirumotecan (sac-TMT) in Combination with Osimertinib as First-Line Treatment for EGFR-Mutant NSCLC Published in Cancer Cell

— The study shows that EGFR-TKIs induce TROP2 upregulation in DTP cells, providing a mechanistic basis for combining sac-TMT with EGFR-TKI.— The Company is...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsStudy

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers